v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Total revenues $ 12,982 $ 35,340
Costs and operating expenses:    
Cost of product revenue 4,521 8,521
Research and development 16,655 19,500
Selling, general and administrative 15,399 15,705
Restructuring charges 72 0
Total costs and operating expenses 36,647 43,726
Loss from operations (23,665) (8,386)
Interest income 1,089 42
Other expense, net (25) (3)
Loss before income taxes (22,601) (8,347)
Provision for income taxes 16 9
Net loss $ (22,617) $ (8,356)
Net loss per share, basic (in dollars per share) $ (0.34) $ (0.13)
Net loss per share, diluted (in dollars per share) $ (0.34) $ (0.13)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 65,931 65,096
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 65,931 65,096
Product revenue    
Revenues:    
Total revenues $ 8,364 $ 30,690
Research and development revenue ($0 and $245 from a related party)    
Revenues:    
Total revenues $ 4,618 $ 4,650

Source